Indoles and benzoimidazoles as modulators of the histamine H4 receptor

Details for Australian Patent Application No. 2007235578 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Edwards, James P.; Shah, Chandravadan R.; Savall, Brad M.

Agent Shelston IP

Pub. Number AU-B-2007235578

PCT Pub. Number WO2007/117401

Priority 60/790,421 07.04.06 US

Filing date 30 March 2007

Wipo publication date 18 October 2007

Acceptance publication date 14 July 2011

International Classifications

C07D 403/02 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/4184 (2006.01)

Event Publications

30 October 2008 PCT application entered the National Phase

  PCT publication WO2007/117401 Priority application(s): WO2007/117401

14 July 2011 Application Accepted

  Published as AU-B-2007235578

10 November 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007235591-Portable dispenser

2007235577-Benzoimidazol-2-yl pyridines as modulators of the histamine H4 receptor